Childhood cancer survival reaches nearly 90%, yet disparities remain
View as a Web Page
News Medical
 
  Oncology Oncology logo  
  The latest oncology news from News Medical  
 New prostate cancer guidelines provide concrete roadmap for patient screeningNew prostate cancer guidelines provide concrete roadmap for patient screening
 
For the first time since 2010, the American Cancer Society (ACS) has updated its prostate cancer screening guidelines, offering specific, age-based recommendations for PSA blood tests and emphasizing secondary testing, like MRIs, before performing biopsies.
 
 
 Childhood cancer survival reaches nearly 90%, yet disparities remainChildhood cancer survival reaches nearly 90%, yet disparities remain
 
Nearly nine in 10 young people with cancer were alive five years after diagnosis by 2017 – up from six in 10 in 1975, according to first comprehensive update of U.S. childhood cancer survival statistics in over a decade published in the Journal of the National Cancer Institute.
 
   Innovative organ-on-a-chip shows how tumors grow and interact with their surroundingsInnovative organ-on-a-chip shows how tumors grow and interact with their surroundings
 
On an organ-on-a-chip researchers can now explore how tumours grow and interact with their surroundings.
 
   DNA damage in T cells limits effectiveness of immunotherapiesDNA damage in T cells limits effectiveness of immunotherapies
 
Immunotherapies, especially immune checkpoint blockers (ICBs) and chimeric antigen receptor (CAR) T cell therapy, depend on functional T cells.
 
   Engineered bacteria carrying two anticancer components shrinks aggressive breast cancer in miceEngineered bacteria carrying two anticancer components shrinks aggressive breast cancer in mice
 
Tumors that resist immune attack, recur, and spread pose a major challenge to cancer treatment. Because certain bacteria naturally accumulate within tumors, they serve as potential carriers for anticancer agents.
 
 Yourgene Health Insight DPYD assay secures TGA regulatory approval in Australia
 
Yourgene Health Insight DPYD assay secures TGA regulatory approval in AustraliaYourgene Health (part of the Novacyt Group), an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces Australian regulatory approval for its Yourgene® Insight DPYD assay.
 
 
 Broad genomic sequencing extends survival in advanced lung cancer patients
 
Broad genomic sequencing extends survival in advanced lung cancer patientsNew research in the November 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that patients with advanced non-small cell lung cancer (NSCLC) lived longer when they received broad-based genomic sequencing (BGS)-testing a large panel of dozens or hundreds of genes at once-before starting treatment, compared with patients who received more limited biomarker testing of just one or two genes.
 
 
 Experimental vaccines aim to treat and prevent aggressive cancers
 
Experimental vaccines aim to treat and prevent aggressive cancersFor more than three decades, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center researchers have pursued an ambitious idea: that vaccines could train the immune system to recognize and fight cancer.
 
 
 Breakthrough RNA blood test identifies hidden ovarian cancer warning signs
 
Breakthrough RNA blood test identifies hidden ovarian cancer warning signsHoag researchers announced a first in the world discovery of a molecular warning signal in the blood that identifies serous tubal intraepithelial carcinoma (STIC), an early, precancerous stage of high-grade serous ovarian cancer (HGSOC).
 
 
 Newly identified enzyme protects growth protein in leukemia cells
 
Newly identified enzyme protects growth protein in leukemia cellsA research team has identified an enzyme that helps acute myeloid leukemia (AML) cells survive by protecting c-MYC, a protein that drives cell growth, from degradation.
 
 
 New surgical approaches aim to improve stomach cancer outcomes
 
New surgical approaches aim to improve stomach cancer outcomesSometimes innovation in cancer care means developing something entirely new. Other times, it means returning to an old idea with the knowledge and tools to make it work better.
 
 
 Oral leukemia therapy offers effective at-home care for older adults
 
Oral leukemia therapy offers effective at-home care for older adultsFor years, older patients with acute myeloid leukemia-an aggressive cancer of the blood and bone marrow-have needed clinic injections five to seven days a month, plus a daily oral pill. For these older patients, that clinic schedule can be quite demanding.
 
 
 Drug combination shows long-term survival in advanced thymic cancer
 
Drug combination shows long-term survival in advanced thymic cancerFinal results from the phase 2 PECATI clinical trial demonstrate encouraging long-term survival outcomes with the combination of lenvatinib and pembrolizumab in patients with previously treated advanced B3-thymoma and thymic carcinoma.
 
 
 DNA methylation profiling stratifies recurrence risk in low-grade endometrial cancer
 
DNA methylation profiling stratifies recurrence risk in low-grade endometrial cancerMolecular diagnostic approaches are expanding what information is available for clinicians and laboratory professionals, including uncovering antimicrobial resistance, identifying pathogens missed by conventional methods, revealing cancer recurrence risks and characterizing complex tumor biology.
 
 
 Researchers uncover how surrounding cells fuel triple-negative breast cancer growth
 
Researchers uncover how surrounding cells fuel triple-negative breast cancer growthTriple-negative breast cancer, which accounts for approximately 10–15% of all breast cancer cases, is considered particularly difficult to treat because it grows rapidly and carries a high risk of recurrence.
 
 
 Can psychedelics help treat cancer beyond easing end-of-life fear?
 
Can psychedelics help treat cancer beyond easing end-of-life fear?A new peer-reviewed review in Psychedelics opens on a strange fact, gathered from existing laboratory studies rather than new experiments: a brain tumor can learn to eavesdrop.
 
 
 Clinical trial of triple combination therapy reveals clues to lung cancer treatment resistance
 
Clinical trial of triple combination therapy reveals clues to lung cancer treatment resistanceIn a new clinical trial, researchers have interrogated how patients with an aggressive form of lung cancer respond to treatment with a triple combination therapy.
 
 
 Maternal nanoplastic exposure left newborn mice with fewer ovarian follicles
 
Maternal nanoplastic exposure left newborn mice with fewer ovarian folliclesResearchers found that maternal exposure to polystyrene nanoplastics disrupted early ovarian development in female mouse offspring, reducing primordial follicle numbers by approximately 22%. The findings linked impaired follicle formation to altered adhesion between immature egg cells, reduced granulosa cell proliferation, and increased apoptosis, although the long-term effects on fertility and relevance to humans remain uncertain.
 
 
 Tumor protein patterns predict how melanoma patients respond to immunotherapy
 
Tumor protein patterns predict how melanoma patients respond to immunotherapyProtein patterns in melanoma tumors can predict how patients respond to immunotherapy and can be used to find promising biomarkers and drug targets, according to two new University of Pittsburgh studies.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney

Copyright © 2000-2026